B7-33
<
>
B7-33
B7-33

B7-33


B7-33 B2B Inquiry Guide

  • Request current specification, packaging, and availability before ordering.
  • Share quantity, destination country, and preferred contact method for a faster quotation.
  • Ask for COA or product-related quality documents during the inquiry process.

This product page is intended for qualified business, laboratory, or research-related inquiry. Availability and permitted use depend on destination country and local regulations.

B7-33 Procurement Information

Specification Request

Confirm product name, preferred specification, quantity, and packaging requirement before quotation.

Document Support

Ask for available specification sheet, packaging details, or product-related quality documentation.

Quotation Follow-up

Use Inquiry Cart or the quote form so our team can reply with availability, lead time, and shipping communication.

Categories:

  • Description
  • Additional information

Basic Info.

B7-33 is a novel, synthetic compound that was first discovered and developed by a team of researchers at the Monash University in Australia. The development of B7-33 was based on the discovery of the relaxin receptor 1 (RXFP1) and the recognition of its potential as a therapeutic target for a wide range of diseases and conditions.

The research team, led by Professor David Handelsman, first synthesized B7-33 in the early 2010s as part of their efforts to develop a functionally selective agonist for RXFP1. This compound was then tested in a series of in vitro and in vivo studies, which demonstrated its potential as a treatment for hypertension, kidney disease, and heart failure. The team's research on B7-33 was published in several scientific journals, including the Journal of Biological Chemistry and the Journal of Hypertension. 

These publications highlighted the compound's unique mechanism of action and its potential as a treatment option for patients.

 

Request a Quote

Send your quantity, destination country, and preferred contact method. Our team will reply with availability and quotation details.

Categories

Go Back Top